Analyst Update: Aptevo Therapeutics Inc, PBF Energy Inc, and Cyberark Software Ltd

Analysts are weighing in on Aptevo Therapeutics Inc (NASDAQ:APVO), PBF Energy Inc (NYSE:PBF), and Cyberark Software Ltd (NASDAQ:CYBR)

Sep 9, 2016 at 2:48 PM
facebook twitter linkedin


Analysts are weighing in on biotech Aptevo Therapeutics Inc (NASDAQ:APVO), petroleum refiner PBF Energy Inc (NYSE:PBF), and tech stock Cyberark Software Ltd (NASDAQ:CYBR). Here's a quick roundup of today's brokerage notes on APVO, PBF, and CYBR.

  • APVO is up 12.5% at $2.48, after Piper Jaffray initiated coverage with an "overweight" opinion and a $7 price target, calling the biotech stock a "value-play." Aptevo Therapeutics Inc is new to Wall Street, opening for public trade less than two months ago and hitting a record high of $8.29 in late July. Obviously, it's had a rough time on the charts since then -- today notwithstanding -- attracting bearish traders all the while. For instance, over 9% of APVO's float is currently sold short

  • PBF has dropped 7% to trade at $21.35, after Goldman Sachs downgraded the stock to "sell" from "neutral," and cut its price target to $10 from $23 -- citing several factors, including a poor outlook for East Coast refining. Most analysts are already bearish on PBF Energy Inc, with 60% giving it a "hold" or a "sell" rating. At the same time, more price-target cuts could come the stock's way if it adds to its 42% year-to-date loss. Specifically, PBF's average 12-month price target stands at $28.83, well above current levels.

  • UBS initiated coverage on CYBR with a "neutral" rating and a $56 price target, yet the stock is 5.3% lower at $51.98 amid broad-market headwinds. Still, the shares appear to be finding support near the $51 level, an area that's contained their pullbacks since early July. Cyberark Software Ltd remains 15.1% higher in 2016, and most analysts seem very optimistic. For instance, 11 of 13 brokerage firms recommend buying the stock, and none consider it a "sell." 
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check
 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners